Menu Back toLS14: Global Oncology Development - Aiming to Be A Game Changer
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
18th DIA Japan Annual Meeting 2021
All prices are exclusive of 10% Japanese consumption tax
LS14: Global Oncology Development - Aiming to Be A Game Changer
Hironobu Saito, PhD
- Corporate Officer /Head of Medical Affairs Div.
- Daiichi Sankyo Co., Ltd., Japan
- Vice President
- 3H Clinical Trial Inc., Japan